PTC299
| CAS No. | 1256565-36-2 | Cat. No. | BCP32869 |
| Name | PTC299 | ||
| Synonyms | PTC-299;PTC 299; | ||
| Formula | C25H20Cl2N2O3 | M. Wt | 467.34 |
| Description | PTC299 is a potent, orally bioavailable VEGFA inhibitor, targets dihydroorotate dehydrogenase (DHODH), resulting in cell growth inhibition and differentiation in leukemias, including acute myeloid leukemia, linking DHODH regulation and stress-induced VEGFA and angiogenesis. | ||
| Pathways | Angiogenesis/Protein Tyrosine Kinase Cell Cycle/DNA Damage | ||
| Targets | DNA/RNA Synthesis VEGFR | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.